biomedicina slovenica


pr=Berkhof : 7

  1. Arbyn Marc; Canfell Karen; Poljak Mario; Berkhof Johannes; de Sanjosé Silvia; Wentzensen Nicolas
    HPV mRNA testing in cervical cancer screening
    2022
  2. Arbyn Marc; Simon Marie; Peeters Eliana; Xu Lan; Meijer Chris J.L.M.; Berkhof Johannes; Cuschieri Kate S.; Bonde Jesper; Oštrbenk Valenčak Anja; Poljak Mario
    2020 list of human papillomavirus assays suitable for primary cervical cancer screening
    2021
  3. Rossi Paolo Giorgi; Ronco Guglielmo; Dillner J.; Elfström K. Miriam; Snijders Peter .J.F.; Arbyn Marc; Berkhof Johannes; Carozzi Francesca; Del Mistro Annarosa; Poljak Mario
    Why follow-back studies should be interpreted cautiously
    2016
  4. Kocjan Boštjan; Bzhalava D.; Forslund O.; Berkhof Johannes; Dillner J.; Poljak Mario
    Molecular methods for identification and characterization of novel papillomaviruses
    2015
  5. Arbyn Marc; Snijders P.J.F.; Meijer C. J. L. M.; Berkhof Johannes; Cuschieri Kate S.; Kocjan Boštjan; Poljak Mario
    Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
    2015
  6. Poljak Mario; Rogovskaya Svetlana; Kesić Vesna; Bray Freddie; Berkhof Johannes; Seme Katja; Brotons Maria; Castellsagué Xavier; Syrjänen Stina; Arbyn Marc; Bosch Francesc Xavier
    Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia
    2013
  7. Hesselink A. T.; Meijer C. J. L. M.; Poljak Mario; Berkhof J.
    Clinical validation of the Abbott RealTime High Risk (HR) HPV assay according to the guidelines for HPV DNA test requirements for cervical screening
    2013


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics